Michael L. Peterson - 16 Jan 2023 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)

Role: Director
Signature: /s/ Michael L. Peterson
Issuer symbol: SCNX
Transactions as of: 16 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Jan 2023, 15:15:19 UTC
Previous filing: 06 Jan 2023
Next filing: 17 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDS	Common stock	Award	$0	+100,000	+528%	$0.000000	118,940	16 Jan 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEDS	Stock Option	Award	$0	+135,802		$0.000000	135,802	16 Jan 2023	Common Stock	135,802	$0.4050	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/8th of such shares per quarter (on the first day of each calendar quarter), with the first vesting beginning on April 1, 2023, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.
F2	Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer and Chairperson of the Audit Committee. Issued under the Issuer's Amended and Restated 2019 Equity Incentive Plan.
F3	The options vest at the rate of 1/2 of such options per year, on January 4, 2024 and 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.